eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants

LOS ANGELES, CA / ACCESS Newswire / June 8, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Company") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced the pricing of its public offering of units, each consisting of two shares of common stock and one common stock purchase warrant.

The Company has sold 592,270 shares of common stock together with 296,135 warrants as units, each unit consisting of two shares of common stock and one warrant to purchase one share of common stock. The units will separate immediately upon issuance and all shares of common stock and warrants that comprise the units are being issued as separate securities. The public offering price for a unit is $18.00.

Total gross proceeds from the offering are expected to be approximately $5.33 million before deducting underwriting discounts, commissions, and estimated offering expenses. The offering is expected to close on June 9, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriter a 45 day option to purchase up to 44,420 units at the unit offering price, less underwriting discounts and commissions, solely to cover over-allotments, if any.

Each warrant will be exercisable commencing the first anniversary of the date of this offering at an exercise price of $11.24 per share and will expire five years from the date of issuance. Commencing from the date they become exercisable, the warrants may be redeemed by the Company, for $0.01 per underlying share, if the Company's common stock trades at a price of $17.98 per share or higher (subject to adjustment for forward and reverse stock splits, recapitalizations, stock dividends and similar transactions after the initial exercise date), on any twenty (20) trading days during any thirty (30) trading day period. The exercise price of a warrant may be reset to $0.001 per underlying share, if within 12 months of the offering the Company sells in a public or private offering additional shares of common stock, or preferred stock or other securities convertible into shares of common stock, at a price (or equivalent) that is less than $8.99 per share. To qualify for the warrant reset, if any, an original purchaser of a unit in this offering must hold and not sell all the shares of common stock purchased in this offering up until the date of the warrant reset event. The warrants will not be listed on any national trading market or other trading medium.

Schreibe Deinen Kommentar